Back to Agenda
Session 1: Regional and Global Regulatory Priority Updates
Session Chair(s)
Peter Baker
International Relations Specialist, OIP, OGROP, FDA, United States
This session is intended for each National Regulatory Authority (NRA) to provide a summary of the progress made on regional regulatory projects. Each NRA will be allotted approximately 10-20 minutes to provide an update on progress made on various domestic and regional projects (e.g. PAHO, PANDRH) that affect regulators and manufacturers in Latin America. The session will culminate in a Q&A panel discussion to provide additional clarification where necessary.
Learning Objective : At the conclusion of this session, participants should be able to:
Speaker(s)
Ariel Arias
Senior Advisor, Centre for Biologics Evaluation, BGTD, Health Canada, Canada
Speaker
Ana Pineda Zavaleta, MSC
International Regulatory Analyst, LAO, OGPS, OPLIA, OC, FDA, United States
Speaker
Daniela Marreco Cerqueira, MS
Associate Director, Third Directorate, ANVISA, Brazil
Speaker
Reina de Acosta
Directora Nacional, Direccion Nacinal de Medicamentos, El Salvador
Speaker
Patricia Aprea, MD
Director, Evaluation and Control of Biológicals/Research, ANMAT, Argentina
Speaker
Have an account?